Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that...
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers.
Target Price
The average target price of INGN is 13 and suggests 112% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell